Antibacterial peptides in dermatology - strategies for evaluation of allergic potential
Milena Deptuła , Anna Wardowska , Maria Dzierżyńska , Sylwia Rodziewicz-Motowidło , Michał Pikuła
AbstractDuring recent decades, the market for peptide-based drugs, including antimicrobial peptides, has vastly extended and evolved. These drugs can be useful in treatment of various types of disorders, e.g., cancer, autoimmune diseases, infections, and non-healing wounds. Although peptides are less immunogenic than other biologic therapeutics, they can still induce immune responses and cause allergies. It is important to evaluate the immunogenic and allergic potential of peptides before they are forwarded to the expensive stages of clinical trials. The process of the evaluation of immunogenicity and cytotoxicity is complicated, as in vitro models and bioinformatics tools cannot fully simulate situations in the clinic. Nevertheless, several potentially promising tests for the preclinical evaluation of peptide drugs have been implemented (e.g., cytotoxicity assays, the basophil activation test, and lymphocyte activation assays). In this review, we focus on strategies for evaluation of the allergic potential of peptide-based therapeutics.
|Journal series||Molecules, ISSN , e-ISSN 1420-3049, (A 30 pkt)|
|License||Journal (articles only); published final; ; with publication|
|Score|| = 30.0, 26-11-2018, ArticleFromJournal|
= 30.0, 26-11-2018, ArticleFromJournal
|Publication indicators||: 2016 = 2.861 (2) - 2016=2.988 (5)|
* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.